| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Oncology &Int?l | President, U.s. Market | SVP, U.s. Market
1 company
Oosthuizen Johannes Jacobus is an EVP, Oncology &Int?l at Merck & Co., Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | MRK Merck & Co., Inc. | President, U.s. Market | Sell | 8,500 | $84.09 | $714,744.60 | -21.7% | -8.9% | +42.4% | |
| Feb 2, 2024 | MRK Merck & Co., Inc. | President, U.s. Market | Sale+OE | 18,959 | $127.17 | $2,411,110.82 | -44.8% | +2.1% | -19.7% | |
| Nov 9, 2023 | MRK Merck & Co., Inc. | President, U.s. Market | Sell | 2,081 | $102.38 | $213,061.31 | -10.3% | +25.4% | +3.2% | |
| Nov 9, 2022 | MRK Merck & Co., Inc. | President, U.s. Market | Sell | 1,795 | $103.21 | $185,261.95 | -9.7% | +4.7% | +3.5% | |
| Nov 7, 2022 | MRK Merck & Co., Inc. | President, U.s. Market | Sale+OE | 45,561 | $99.47 | $4,531,980.01 | -71.1% | +4.6% | +6.8% | |
| Oct 28, 2022 | MRK Merck & Co., Inc. | President, U.s. Market | Sale+OE | 3,633 | $100.21 | $364,064.75 | -25.0% | +6.8% | +4.8% |